nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—HRH1—atherosclerosis	0.292	0.812	CbGaD
Amitriptyline—ALB—atherosclerosis	0.0675	0.188	CbGaD
Amitriptyline—ALB—Rosuvastatin—atherosclerosis	0.0229	0.0612	CbGbCtD
Amitriptyline—CYP2B6—Simvastatin—atherosclerosis	0.0217	0.0581	CbGbCtD
Amitriptyline—CYP3A5—Rosuvastatin—atherosclerosis	0.0184	0.0492	CbGbCtD
Amitriptyline—CYP3A5—Simvastatin—atherosclerosis	0.0171	0.0458	CbGbCtD
Amitriptyline—CYP3A5—Pravastatin—atherosclerosis	0.0167	0.0448	CbGbCtD
Amitriptyline—CYP3A5—Lovastatin—atherosclerosis	0.0167	0.0448	CbGbCtD
Amitriptyline—CYP2C8—Simvastatin—atherosclerosis	0.0164	0.044	CbGbCtD
Amitriptyline—CYP2C8—Lovastatin—atherosclerosis	0.0161	0.043	CbGbCtD
Amitriptyline—CYP2C8—Pravastatin—atherosclerosis	0.0161	0.043	CbGbCtD
Amitriptyline—CYP2C19—Rosuvastatin—atherosclerosis	0.0148	0.0397	CbGbCtD
Amitriptyline—CYP2C19—Simvastatin—atherosclerosis	0.0138	0.0369	CbGbCtD
Amitriptyline—CYP2C19—Lovastatin—atherosclerosis	0.0135	0.0361	CbGbCtD
Amitriptyline—CYP2D6—Niacin—atherosclerosis	0.0133	0.0355	CbGbCtD
Amitriptyline—CYP2C9—Rosuvastatin—atherosclerosis	0.0123	0.033	CbGbCtD
Amitriptyline—ABCB1—Ezetimibe—atherosclerosis	0.012	0.032	CbGbCtD
Amitriptyline—CYP2C9—Simvastatin—atherosclerosis	0.0115	0.0307	CbGbCtD
Amitriptyline—CYP2C9—Lovastatin—atherosclerosis	0.0112	0.03	CbGbCtD
Amitriptyline—CYP2C9—Pravastatin—atherosclerosis	0.0112	0.03	CbGbCtD
Amitriptyline—ABCB1—Simvastatin—atherosclerosis	0.0111	0.0298	CbGbCtD
Amitriptyline—ABCB1—Lovastatin—atherosclerosis	0.0109	0.0291	CbGbCtD
Amitriptyline—ABCB1—Pravastatin—atherosclerosis	0.0109	0.0291	CbGbCtD
Amitriptyline—CYP2D6—Simvastatin—atherosclerosis	0.0105	0.0281	CbGbCtD
Amitriptyline—CYP2D6—Pravastatin—atherosclerosis	0.0103	0.0275	CbGbCtD
Amitriptyline—CYP2D6—Lovastatin—atherosclerosis	0.0103	0.0275	CbGbCtD
Amitriptyline—CYP3A4—Ezetimibe—atherosclerosis	0.00717	0.0192	CbGbCtD
Amitriptyline—CYP3A4—Rosuvastatin—atherosclerosis	0.00717	0.0192	CbGbCtD
Amitriptyline—CYP3A4—Simvastatin—atherosclerosis	0.00666	0.0178	CbGbCtD
Amitriptyline—CYP3A4—Lovastatin—atherosclerosis	0.00652	0.0175	CbGbCtD
Amitriptyline—CYP3A4—Pravastatin—atherosclerosis	0.00652	0.0175	CbGbCtD
Amitriptyline—Antinuclear antibody positive—Lovastatin—atherosclerosis	0.00401	0.0364	CcSEcCtD
Amitriptyline—Lupus-like syndrome—Lovastatin—atherosclerosis	0.00387	0.035	CcSEcCtD
Amitriptyline—Lupus-like syndrome—Ezetimibe—atherosclerosis	0.00379	0.0344	CcSEcCtD
Amitriptyline—Antinuclear antibody positive—Simvastatin—atherosclerosis	0.00375	0.034	CcSEcCtD
Amitriptyline—Lupus-like syndrome—Simvastatin—atherosclerosis	0.00362	0.0328	CcSEcCtD
Amitriptyline—Antinuclear antibody positive—Pravastatin—atherosclerosis	0.00339	0.0307	CcSEcCtD
Amitriptyline—HTR2A—arteriole—atherosclerosis	0.00201	0.066	CbGeAlD
Amitriptyline—HTR7—vein—atherosclerosis	0.00192	0.0631	CbGeAlD
Amitriptyline—Sleep disturbance—Simvastatin—atherosclerosis	0.00152	0.0138	CcSEcCtD
Amitriptyline—Sleep disturbance—Pravastatin—atherosclerosis	0.00137	0.0125	CcSEcCtD
Amitriptyline—NTRK2—connective tissue—atherosclerosis	0.00137	0.045	CbGeAlD
Amitriptyline—HTR2A—vein—atherosclerosis	0.0012	0.0394	CbGeAlD
Amitriptyline—NTRK2—cardiovascular system—atherosclerosis	0.00119	0.0392	CbGeAlD
Amitriptyline—NTRK2—adipose tissue—atherosclerosis	0.00105	0.0345	CbGeAlD
Amitriptyline—Nightmare—Rosuvastatin—atherosclerosis	0.00104	0.0094	CcSEcCtD
Amitriptyline—HTR1B—artery—atherosclerosis	0.00101	0.0333	CbGeAlD
Amitriptyline—HTR1D—artery—atherosclerosis	0.000981	0.0323	CbGeAlD
Amitriptyline—Tingling sensation—Niacin—atherosclerosis	0.000973	0.00882	CcSEcCtD
Amitriptyline—Gynaecomastia—Rosuvastatin—atherosclerosis	0.000962	0.00871	CcSEcCtD
Amitriptyline—Numbness—Pravastatin—atherosclerosis	0.000929	0.00842	CcSEcCtD
Amitriptyline—KCNQ3—cardiovascular system—atherosclerosis	0.000902	0.0297	CbGeAlD
Amitriptyline—Sleep disorder—Rosuvastatin—atherosclerosis	0.000901	0.00817	CcSEcCtD
Amitriptyline—Sensory loss—Pravastatin—atherosclerosis	0.000889	0.00806	CcSEcCtD
Amitriptyline—Hepatic failure—Rosuvastatin—atherosclerosis	0.000868	0.00787	CcSEcCtD
Amitriptyline—Nightmare—Simvastatin—atherosclerosis	0.000823	0.00746	CcSEcCtD
Amitriptyline—Gynaecomastia—Lovastatin—atherosclerosis	0.000815	0.00739	CcSEcCtD
Amitriptyline—HTR2A—hindlimb—atherosclerosis	0.000795	0.0262	CbGeAlD
Amitriptyline—HTR1B—blood vessel—atherosclerosis	0.00079	0.026	CbGeAlD
Amitriptyline—KCND2—cardiovascular system—atherosclerosis	0.000786	0.0259	CbGeAlD
Amitriptyline—HTR7—artery—atherosclerosis	0.000782	0.0257	CbGeAlD
Amitriptyline—HTR1D—blood vessel—atherosclerosis	0.000764	0.0251	CbGeAlD
Amitriptyline—Gynaecomastia—Simvastatin—atherosclerosis	0.000762	0.00691	CcSEcCtD
Amitriptyline—Nightmare—Pravastatin—atherosclerosis	0.000744	0.00674	CcSEcCtD
Amitriptyline—Vascular purpura—Lovastatin—atherosclerosis	0.000739	0.0067	CcSEcCtD
Amitriptyline—Hepatic failure—Lovastatin—atherosclerosis	0.000736	0.00667	CcSEcCtD
Amitriptyline—Hepatic failure—Ezetimibe—atherosclerosis	0.000722	0.00654	CcSEcCtD
Amitriptyline—Sleep disorder—Simvastatin—atherosclerosis	0.000714	0.00647	CcSEcCtD
Amitriptyline—KCND2—adipose tissue—atherosclerosis	0.000693	0.0228	CbGeAlD
Amitriptyline—Vascular purpura—Simvastatin—atherosclerosis	0.000691	0.00626	CcSEcCtD
Amitriptyline—Gynaecomastia—Pravastatin—atherosclerosis	0.000689	0.00625	CcSEcCtD
Amitriptyline—Hepatic failure—Simvastatin—atherosclerosis	0.000688	0.00624	CcSEcCtD
Amitriptyline—Purpura—Lovastatin—atherosclerosis	0.000686	0.00622	CcSEcCtD
Amitriptyline—KCND3—cardiovascular system—atherosclerosis	0.000685	0.0225	CbGeAlD
Amitriptyline—HTR2A—appendage—atherosclerosis	0.000682	0.0224	CbGeAlD
Amitriptyline—Arthritis—Lovastatin—atherosclerosis	0.00068	0.00616	CcSEcCtD
Amitriptyline—Arthritis—Ezetimibe—atherosclerosis	0.000667	0.00605	CcSEcCtD
Amitriptyline—HTR7—endothelium—atherosclerosis	0.00066	0.0217	CbGeAlD
Amitriptyline—Sleep disorder—Pravastatin—atherosclerosis	0.000646	0.00585	CcSEcCtD
Amitriptyline—Purpura—Simvastatin—atherosclerosis	0.000642	0.00581	CcSEcCtD
Amitriptyline—Arthritis—Simvastatin—atherosclerosis	0.000636	0.00577	CcSEcCtD
Amitriptyline—Vascular purpura—Pravastatin—atherosclerosis	0.000625	0.00566	CcSEcCtD
Amitriptyline—Hepatic failure—Pravastatin—atherosclerosis	0.000622	0.00564	CcSEcCtD
Amitriptyline—HTR7—blood vessel—atherosclerosis	0.000609	0.02	CbGeAlD
Amitriptyline—KCND3—adipose tissue—atherosclerosis	0.000604	0.0199	CbGeAlD
Amitriptyline—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000589	0.00534	CcSEcCtD
Amitriptyline—Jaundice—Rosuvastatin—atherosclerosis	0.000586	0.00531	CcSEcCtD
Amitriptyline—Arthritis—Niacin—atherosclerosis	0.000584	0.00529	CcSEcCtD
Amitriptyline—Purpura—Pravastatin—atherosclerosis	0.00058	0.00526	CcSEcCtD
Amitriptyline—Arthritis—Pravastatin—atherosclerosis	0.000575	0.00521	CcSEcCtD
Amitriptyline—Eosinophilia—Lovastatin—atherosclerosis	0.000566	0.00513	CcSEcCtD
Amitriptyline—Disturbance in sexual arousal—Niacin—atherosclerosis	0.000563	0.00511	CcSEcCtD
Amitriptyline—Eosinophilia—Ezetimibe—atherosclerosis	0.000555	0.00503	CcSEcCtD
Amitriptyline—Phenindamine—HRH1—atherosclerosis	0.000554	0.101	CrCbGaD
Amitriptyline—Urinary retention—Niacin—atherosclerosis	0.00054	0.00489	CcSEcCtD
Amitriptyline—Hepatitis—Rosuvastatin—atherosclerosis	0.00054	0.00489	CcSEcCtD
Amitriptyline—HRH2—cardiovascular system—atherosclerosis	0.000534	0.0176	CbGeAlD
Amitriptyline—Eosinophilia—Simvastatin—atherosclerosis	0.000529	0.0048	CcSEcCtD
Amitriptyline—Erectile dysfunction—Lovastatin—atherosclerosis	0.000526	0.00477	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Niacin—atherosclerosis	0.000519	0.0047	CcSEcCtD
Amitriptyline—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000516	0.00468	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000499	0.00453	CcSEcCtD
Amitriptyline—Erectile dysfunction—Simvastatin—atherosclerosis	0.000492	0.00446	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00049	0.00444	CcSEcCtD
Amitriptyline—HTR2A—artery—atherosclerosis	0.000487	0.016	CbGeAlD
Amitriptyline—Jaundice—Ezetimibe—atherosclerosis	0.000487	0.00441	CcSEcCtD
Amitriptyline—Arrhythmia—Rosuvastatin—atherosclerosis	0.000482	0.00437	CcSEcCtD
Amitriptyline—Eosinophilia—Pravastatin—atherosclerosis	0.000478	0.00434	CcSEcCtD
Amitriptyline—Sweating increased—Pravastatin—atherosclerosis	0.000471	0.00427	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000467	0.00423	CcSEcCtD
Amitriptyline—Jaundice—Simvastatin—atherosclerosis	0.000465	0.00421	CcSEcCtD
Amitriptyline—Hepatitis—Lovastatin—atherosclerosis	0.000457	0.00415	CcSEcCtD
Amitriptyline—Erectile dysfunction—Niacin—atherosclerosis	0.000452	0.0041	CcSEcCtD
Amitriptyline—Hepatitis—Ezetimibe—atherosclerosis	0.000449	0.00407	CcSEcCtD
Amitriptyline—Erectile dysfunction—Pravastatin—atherosclerosis	0.000445	0.00403	CcSEcCtD
Amitriptyline—Weight increased—Pravastatin—atherosclerosis	0.00044	0.00399	CcSEcCtD
Amitriptyline—Azatadine—HRH1—atherosclerosis	0.000432	0.0787	CrCbGaD
Amitriptyline—Hepatitis—Simvastatin—atherosclerosis	0.000428	0.00388	CcSEcCtD
Amitriptyline—Jaundice—Niacin—atherosclerosis	0.000427	0.00387	CcSEcCtD
Amitriptyline—Stomatitis—Niacin—atherosclerosis	0.000427	0.00387	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000425	0.00385	CcSEcCtD
Amitriptyline—KCND3—liver—atherosclerosis	0.000424	0.0139	CbGeAlD
Amitriptyline—Myocardial infarction—Pravastatin—atherosclerosis	0.000422	0.00383	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000422	0.00383	CcSEcCtD
Amitriptyline—Jaundice—Pravastatin—atherosclerosis	0.00042	0.00381	CcSEcCtD
Amitriptyline—HTR2A—endothelium—atherosclerosis	0.000412	0.0135	CbGeAlD
Amitriptyline—Alopecia—Lovastatin—atherosclerosis	0.000404	0.00366	CcSEcCtD
Amitriptyline—Alopecia—Ezetimibe—atherosclerosis	0.000396	0.00359	CcSEcCtD
Amitriptyline—Hepatitis—Niacin—atherosclerosis	0.000393	0.00356	CcSEcCtD
Amitriptyline—HTR1D—connective tissue—atherosclerosis	0.000392	0.0129	CbGeAlD
Amitriptyline—Hypoaesthesia—Niacin—atherosclerosis	0.000391	0.00354	CcSEcCtD
Amitriptyline—Dysgeusia—Lovastatin—atherosclerosis	0.00039	0.00353	CcSEcCtD
Amitriptyline—Hepatitis—Pravastatin—atherosclerosis	0.000387	0.00351	CcSEcCtD
Amitriptyline—Confusional state—Rosuvastatin—atherosclerosis	0.000387	0.0035	CcSEcCtD
Amitriptyline—Hypoaesthesia—Pravastatin—atherosclerosis	0.000385	0.00349	CcSEcCtD
Amitriptyline—Pheniramine—HRH1—atherosclerosis	0.000382	0.0696	CrCbGaD
Amitriptyline—HTR2A—blood vessel—atherosclerosis	0.00038	0.0125	CbGeAlD
Amitriptyline—Alopecia—Simvastatin—atherosclerosis	0.000378	0.00343	CcSEcCtD
Amitriptyline—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000375	0.0034	CcSEcCtD
Amitriptyline—Vision blurred—Lovastatin—atherosclerosis	0.000375	0.0034	CcSEcCtD
Amitriptyline—Tremor—Lovastatin—atherosclerosis	0.000373	0.00338	CcSEcCtD
Amitriptyline—Ill-defined disorder—Lovastatin—atherosclerosis	0.000369	0.00335	CcSEcCtD
Amitriptyline—Tinnitus—Niacin—atherosclerosis	0.000366	0.00332	CcSEcCtD
Amitriptyline—Dysgeusia—Simvastatin—atherosclerosis	0.000365	0.00331	CcSEcCtD
Amitriptyline—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000362	0.00328	CcSEcCtD
Amitriptyline—Tinnitus—Pravastatin—atherosclerosis	0.000361	0.00327	CcSEcCtD
Amitriptyline—Malaise—Lovastatin—atherosclerosis	0.000359	0.00325	CcSEcCtD
Amitriptyline—Leukopenia—Lovastatin—atherosclerosis	0.000356	0.00323	CcSEcCtD
Amitriptyline—HTR1B—cardiovascular system—atherosclerosis	0.000352	0.0116	CbGeAlD
Amitriptyline—Malaise—Ezetimibe—atherosclerosis	0.000352	0.00319	CcSEcCtD
Amitriptyline—Vision blurred—Simvastatin—atherosclerosis	0.000351	0.00318	CcSEcCtD
Amitriptyline—Arrhythmia—Niacin—atherosclerosis	0.000351	0.00318	CcSEcCtD
Amitriptyline—CHRM2—cardiovascular system—atherosclerosis	0.00035	0.0115	CbGeAlD
Amitriptyline—Tremor—Simvastatin—atherosclerosis	0.000349	0.00316	CcSEcCtD
Amitriptyline—Clofedanol—HRH1—atherosclerosis	0.000348	0.0634	CrCbGaD
Amitriptyline—Alopecia—Niacin—atherosclerosis	0.000347	0.00315	CcSEcCtD
Amitriptyline—Insomnia—Rosuvastatin—atherosclerosis	0.000347	0.00314	CcSEcCtD
Amitriptyline—Ill-defined disorder—Simvastatin—atherosclerosis	0.000346	0.00313	CcSEcCtD
Amitriptyline—Arrhythmia—Pravastatin—atherosclerosis	0.000346	0.00313	CcSEcCtD
Amitriptyline—Palpitations—Ezetimibe—atherosclerosis	0.000345	0.00313	CcSEcCtD
Amitriptyline—Paraesthesia—Rosuvastatin—atherosclerosis	0.000344	0.00312	CcSEcCtD
Amitriptyline—Alopecia—Pravastatin—atherosclerosis	0.000342	0.0031	CcSEcCtD
Amitriptyline—HTR1D—cardiovascular system—atherosclerosis	0.000341	0.0112	CbGeAlD
Amitriptyline—Anxiety—Lovastatin—atherosclerosis	0.000338	0.00306	CcSEcCtD
Amitriptyline—Dyspepsia—Rosuvastatin—atherosclerosis	0.000338	0.00306	CcSEcCtD
Amitriptyline—Hypertension—Ezetimibe—atherosclerosis	0.000337	0.00306	CcSEcCtD
Amitriptyline—Malaise—Simvastatin—atherosclerosis	0.000336	0.00304	CcSEcCtD
Amitriptyline—Discomfort—Lovastatin—atherosclerosis	0.000335	0.00304	CcSEcCtD
Amitriptyline—Leukopenia—Simvastatin—atherosclerosis	0.000333	0.00302	CcSEcCtD
Amitriptyline—Dry mouth—Lovastatin—atherosclerosis	0.000332	0.003	CcSEcCtD
Amitriptyline—HRH2—liver—atherosclerosis	0.00033	0.0109	CbGeAlD
Amitriptyline—Dysgeusia—Pravastatin—atherosclerosis	0.00033	0.00299	CcSEcCtD
Amitriptyline—Discomfort—Ezetimibe—atherosclerosis	0.000329	0.00298	CcSEcCtD
Amitriptyline—Constipation—Rosuvastatin—atherosclerosis	0.000328	0.00297	CcSEcCtD
Amitriptyline—Confusional state—Lovastatin—atherosclerosis	0.000328	0.00297	CcSEcCtD
Amitriptyline—Dry mouth—Ezetimibe—atherosclerosis	0.000325	0.00295	CcSEcCtD
Amitriptyline—Vision blurred—Niacin—atherosclerosis	0.000322	0.00292	CcSEcCtD
Amitriptyline—Confusional state—Ezetimibe—atherosclerosis	0.000321	0.00291	CcSEcCtD
Amitriptyline—CHRM1—cardiovascular system—atherosclerosis	0.000319	0.0105	CbGeAlD
Amitriptyline—Doxylamine—HRH1—atherosclerosis	0.000318	0.058	CrCbGaD
Amitriptyline—Thrombocytopenia—Lovastatin—atherosclerosis	0.000318	0.00288	CcSEcCtD
Amitriptyline—Vision blurred—Pravastatin—atherosclerosis	0.000317	0.00288	CcSEcCtD
Amitriptyline—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000316	0.00286	CcSEcCtD
Amitriptyline—Anxiety—Simvastatin—atherosclerosis	0.000316	0.00286	CcSEcCtD
Amitriptyline—Tremor—Pravastatin—atherosclerosis	0.000315	0.00286	CcSEcCtD
Amitriptyline—Discomfort—Simvastatin—atherosclerosis	0.000313	0.00284	CcSEcCtD
Amitriptyline—Ill-defined disorder—Pravastatin—atherosclerosis	0.000312	0.00283	CcSEcCtD
Amitriptyline—HTR7—connective tissue—atherosclerosis	0.000312	0.0103	CbGeAlD
Amitriptyline—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000312	0.00283	CcSEcCtD
Amitriptyline—Anorexia—Lovastatin—atherosclerosis	0.00031	0.00281	CcSEcCtD
Amitriptyline—Syncope—Niacin—atherosclerosis	0.000307	0.00278	CcSEcCtD
Amitriptyline—Confusional state—Simvastatin—atherosclerosis	0.000306	0.00278	CcSEcCtD
Amitriptyline—Leukopenia—Niacin—atherosclerosis	0.000306	0.00277	CcSEcCtD
Amitriptyline—Urticaria—Rosuvastatin—atherosclerosis	0.000305	0.00276	CcSEcCtD
Amitriptyline—Oedema—Simvastatin—atherosclerosis	0.000304	0.00275	CcSEcCtD
Amitriptyline—Malaise—Pravastatin—atherosclerosis	0.000304	0.00275	CcSEcCtD
Amitriptyline—Tripelennamine—HRH1—atherosclerosis	0.000303	0.0552	CrCbGaD
Amitriptyline—Palpitations—Niacin—atherosclerosis	0.000302	0.00274	CcSEcCtD
Amitriptyline—Leukopenia—Pravastatin—atherosclerosis	0.000301	0.00273	CcSEcCtD
Amitriptyline—Loss of consciousness—Niacin—atherosclerosis	0.000301	0.00272	CcSEcCtD
Amitriptyline—Olopatadine—HRH1—atherosclerosis	0.000299	0.0545	CrCbGaD
Amitriptyline—Thrombocytopenia—Simvastatin—atherosclerosis	0.000298	0.0027	CcSEcCtD
Amitriptyline—Insomnia—Lovastatin—atherosclerosis	0.000294	0.00266	CcSEcCtD
Amitriptyline—Paraesthesia—Lovastatin—atherosclerosis	0.000292	0.00264	CcSEcCtD
Amitriptyline—Hypertension—Pravastatin—atherosclerosis	0.000291	0.00263	CcSEcCtD
Amitriptyline—Anorexia—Simvastatin—atherosclerosis	0.00029	0.00263	CcSEcCtD
Amitriptyline—Insomnia—Ezetimibe—atherosclerosis	0.000288	0.00261	CcSEcCtD
Amitriptyline—Paraesthesia—Ezetimibe—atherosclerosis	0.000286	0.00259	CcSEcCtD
Amitriptyline—Dyspepsia—Lovastatin—atherosclerosis	0.000286	0.00259	CcSEcCtD
Amitriptyline—Anxiety—Pravastatin—atherosclerosis	0.000286	0.00259	CcSEcCtD
Amitriptyline—Dry mouth—Niacin—atherosclerosis	0.000285	0.00258	CcSEcCtD
Amitriptyline—HTR1A—cardiovascular system—atherosclerosis	0.000284	0.00935	CbGeAlD
Amitriptyline—Discomfort—Pravastatin—atherosclerosis	0.000283	0.00257	CcSEcCtD
Amitriptyline—Decreased appetite—Lovastatin—atherosclerosis	0.000282	0.00256	CcSEcCtD
Amitriptyline—Dyspepsia—Ezetimibe—atherosclerosis	0.000281	0.00254	CcSEcCtD
Amitriptyline—SIGMAR1—adipose tissue—atherosclerosis	0.00028	0.00922	CbGeAlD
Amitriptyline—Fatigue—Lovastatin—atherosclerosis	0.00028	0.00254	CcSEcCtD
Amitriptyline—Oedema—Niacin—atherosclerosis	0.000279	0.00253	CcSEcCtD
Amitriptyline—Dimetindene—HRH1—atherosclerosis	0.000278	0.0507	CrCbGaD
Amitriptyline—Constipation—Lovastatin—atherosclerosis	0.000278	0.00252	CcSEcCtD
Amitriptyline—Confusional state—Pravastatin—atherosclerosis	0.000277	0.00251	CcSEcCtD
Amitriptyline—Decreased appetite—Ezetimibe—atherosclerosis	0.000277	0.00251	CcSEcCtD
Amitriptyline—Asthenia—Rosuvastatin—atherosclerosis	0.000275	0.00249	CcSEcCtD
Amitriptyline—Insomnia—Simvastatin—atherosclerosis	0.000275	0.00249	CcSEcCtD
Amitriptyline—Oedema—Pravastatin—atherosclerosis	0.000275	0.00249	CcSEcCtD
Amitriptyline—Fatigue—Ezetimibe—atherosclerosis	0.000275	0.00249	CcSEcCtD
Amitriptyline—Shock—Niacin—atherosclerosis	0.000275	0.00249	CcSEcCtD
Amitriptyline—Alimemazine—HRH1—atherosclerosis	0.000273	0.0498	CrCbGaD
Amitriptyline—Paraesthesia—Simvastatin—atherosclerosis	0.000273	0.00247	CcSEcCtD
Amitriptyline—Constipation—Ezetimibe—atherosclerosis	0.000273	0.00247	CcSEcCtD
Amitriptyline—Tachycardia—Niacin—atherosclerosis	0.000272	0.00247	CcSEcCtD
Amitriptyline—HTR7—cardiovascular system—atherosclerosis	0.000272	0.00893	CbGeAlD
Amitriptyline—Pruritus—Rosuvastatin—atherosclerosis	0.000271	0.00246	CcSEcCtD
Amitriptyline—Hyperhidrosis—Niacin—atherosclerosis	0.00027	0.00245	CcSEcCtD
Amitriptyline—Thrombocytopenia—Pravastatin—atherosclerosis	0.000269	0.00244	CcSEcCtD
Amitriptyline—Feeling abnormal—Lovastatin—atherosclerosis	0.000268	0.00243	CcSEcCtD
Amitriptyline—Dyspepsia—Simvastatin—atherosclerosis	0.000268	0.00242	CcSEcCtD
Amitriptyline—Anorexia—Niacin—atherosclerosis	0.000266	0.00241	CcSEcCtD
Amitriptyline—Hyperhidrosis—Pravastatin—atherosclerosis	0.000266	0.00241	CcSEcCtD
Amitriptyline—Decreased appetite—Simvastatin—atherosclerosis	0.000264	0.00239	CcSEcCtD
Amitriptyline—Feeling abnormal—Ezetimibe—atherosclerosis	0.000263	0.00238	CcSEcCtD
Amitriptyline—Diarrhoea—Rosuvastatin—atherosclerosis	0.000262	0.00238	CcSEcCtD
Amitriptyline—Fatigue—Simvastatin—atherosclerosis	0.000262	0.00237	CcSEcCtD
Amitriptyline—ADRA1A—cardiovascular system—atherosclerosis	0.000262	0.00862	CbGeAlD
Amitriptyline—Anorexia—Pravastatin—atherosclerosis	0.000262	0.00237	CcSEcCtD
Amitriptyline—Hypotension—Niacin—atherosclerosis	0.000261	0.00236	CcSEcCtD
Amitriptyline—Constipation—Simvastatin—atherosclerosis	0.00026	0.00236	CcSEcCtD
Amitriptyline—Urticaria—Lovastatin—atherosclerosis	0.000258	0.00234	CcSEcCtD
Amitriptyline—Body temperature increased—Lovastatin—atherosclerosis	0.000257	0.00233	CcSEcCtD
Amitriptyline—Dizziness—Rosuvastatin—atherosclerosis	0.000254	0.0023	CcSEcCtD
Amitriptyline—Urticaria—Ezetimibe—atherosclerosis	0.000253	0.00229	CcSEcCtD
Amitriptyline—Insomnia—Niacin—atherosclerosis	0.000252	0.00229	CcSEcCtD
Amitriptyline—Body temperature increased—Ezetimibe—atherosclerosis	0.000252	0.00228	CcSEcCtD
Amitriptyline—CHRM3—adipose tissue—atherosclerosis	0.000252	0.00828	CbGeAlD
Amitriptyline—Paraesthesia—Niacin—atherosclerosis	0.000251	0.00227	CcSEcCtD
Amitriptyline—Feeling abnormal—Simvastatin—atherosclerosis	0.00025	0.00227	CcSEcCtD
Amitriptyline—Epinastine—HRH1—atherosclerosis	0.00025	0.0455	CrCbGaD
Amitriptyline—Bromodiphenhydramine—HRH1—atherosclerosis	0.000249	0.0454	CrCbGaD
Amitriptyline—ABCB1—blood vessel—atherosclerosis	0.000249	0.00818	CbGeAlD
Amitriptyline—Insomnia—Pravastatin—atherosclerosis	0.000249	0.00225	CcSEcCtD
Amitriptyline—Somnolence—Niacin—atherosclerosis	0.000248	0.00225	CcSEcCtD
Amitriptyline—Paraesthesia—Pravastatin—atherosclerosis	0.000247	0.00224	CcSEcCtD
Amitriptyline—Dyspepsia—Niacin—atherosclerosis	0.000246	0.00223	CcSEcCtD
Amitriptyline—Decreased appetite—Niacin—atherosclerosis	0.000243	0.0022	CcSEcCtD
Amitriptyline—Dyspepsia—Pravastatin—atherosclerosis	0.000242	0.00219	CcSEcCtD
Amitriptyline—Rash—Rosuvastatin—atherosclerosis	0.000242	0.00219	CcSEcCtD
Amitriptyline—Dermatitis—Rosuvastatin—atherosclerosis	0.000242	0.00219	CcSEcCtD
Amitriptyline—Urticaria—Simvastatin—atherosclerosis	0.000241	0.00219	CcSEcCtD
Amitriptyline—Body temperature increased—Simvastatin—atherosclerosis	0.00024	0.00218	CcSEcCtD
Amitriptyline—Headache—Rosuvastatin—atherosclerosis	0.00024	0.00218	CcSEcCtD
Amitriptyline—Decreased appetite—Pravastatin—atherosclerosis	0.000239	0.00216	CcSEcCtD
Amitriptyline—Fatigue—Pravastatin—atherosclerosis	0.000237	0.00215	CcSEcCtD
Amitriptyline—Constipation—Pravastatin—atherosclerosis	0.000235	0.00213	CcSEcCtD
Amitriptyline—Asthenia—Lovastatin—atherosclerosis	0.000233	0.00211	CcSEcCtD
Amitriptyline—HRH1—connective tissue—atherosclerosis	0.000233	0.00767	CbGeAlD
Amitriptyline—ORM1—liver—atherosclerosis	0.000232	0.00764	CbGeAlD
Amitriptyline—ADRA1A—adipose tissue—atherosclerosis	0.000231	0.0076	CbGeAlD
Amitriptyline—Pruritus—Lovastatin—atherosclerosis	0.00023	0.00208	CcSEcCtD
Amitriptyline—ADRA2A—connective tissue—atherosclerosis	0.000229	0.00753	CbGeAlD
Amitriptyline—Asthenia—Ezetimibe—atherosclerosis	0.000229	0.00207	CcSEcCtD
Amitriptyline—Nausea—Rosuvastatin—atherosclerosis	0.000228	0.00206	CcSEcCtD
Amitriptyline—Feeling abnormal—Pravastatin—atherosclerosis	0.000226	0.00205	CcSEcCtD
Amitriptyline—Pruritus—Ezetimibe—atherosclerosis	0.000226	0.00204	CcSEcCtD
Amitriptyline—Diarrhoea—Lovastatin—atherosclerosis	0.000222	0.00201	CcSEcCtD
Amitriptyline—Urticaria—Niacin—atherosclerosis	0.000222	0.00201	CcSEcCtD
Amitriptyline—Body temperature increased—Niacin—atherosclerosis	0.000221	0.002	CcSEcCtD
Amitriptyline—Urticaria—Pravastatin—atherosclerosis	0.000218	0.00198	CcSEcCtD
Amitriptyline—Asthenia—Simvastatin—atherosclerosis	0.000218	0.00198	CcSEcCtD
Amitriptyline—Diarrhoea—Ezetimibe—atherosclerosis	0.000218	0.00198	CcSEcCtD
Amitriptyline—Body temperature increased—Pravastatin—atherosclerosis	0.000217	0.00197	CcSEcCtD
Amitriptyline—Pruritus—Simvastatin—atherosclerosis	0.000215	0.00195	CcSEcCtD
Amitriptyline—Dizziness—Lovastatin—atherosclerosis	0.000215	0.00195	CcSEcCtD
Amitriptyline—Dizziness—Ezetimibe—atherosclerosis	0.000211	0.00191	CcSEcCtD
Amitriptyline—Diarrhoea—Simvastatin—atherosclerosis	0.000208	0.00188	CcSEcCtD
Amitriptyline—CYP2B6—cardiovascular system—atherosclerosis	0.000208	0.00683	CbGeAlD
Amitriptyline—Vomiting—Lovastatin—atherosclerosis	0.000207	0.00187	CcSEcCtD
Amitriptyline—CYP2C9—cardiovascular system—atherosclerosis	0.000206	0.00676	CbGeAlD
Amitriptyline—Rash—Lovastatin—atherosclerosis	0.000205	0.00186	CcSEcCtD
Amitriptyline—Dermatitis—Lovastatin—atherosclerosis	0.000205	0.00186	CcSEcCtD
Amitriptyline—ALB—liver—atherosclerosis	0.000204	0.0067	CbGeAlD
Amitriptyline—Headache—Lovastatin—atherosclerosis	0.000204	0.00184	CcSEcCtD
Amitriptyline—Vomiting—Ezetimibe—atherosclerosis	0.000203	0.00184	CcSEcCtD
Amitriptyline—Dizziness—Simvastatin—atherosclerosis	0.000201	0.00182	CcSEcCtD
Amitriptyline—Rash—Ezetimibe—atherosclerosis	0.000201	0.00182	CcSEcCtD
Amitriptyline—Dermatitis—Ezetimibe—atherosclerosis	0.000201	0.00182	CcSEcCtD
Amitriptyline—Asthenia—Niacin—atherosclerosis	0.0002	0.00181	CcSEcCtD
Amitriptyline—Headache—Ezetimibe—atherosclerosis	0.0002	0.00181	CcSEcCtD
Amitriptyline—Pruritus—Niacin—atherosclerosis	0.000197	0.00179	CcSEcCtD
Amitriptyline—Asthenia—Pravastatin—atherosclerosis	0.000197	0.00179	CcSEcCtD
Amitriptyline—SIGMAR1—liver—atherosclerosis	0.000197	0.00647	CbGeAlD
Amitriptyline—CYP2E1—cardiovascular system—atherosclerosis	0.000195	0.00641	CbGeAlD
Amitriptyline—HTR2A—connective tissue—atherosclerosis	0.000195	0.0064	CbGeAlD
Amitriptyline—Pruritus—Pravastatin—atherosclerosis	0.000194	0.00176	CcSEcCtD
Amitriptyline—Vomiting—Simvastatin—atherosclerosis	0.000193	0.00175	CcSEcCtD
Amitriptyline—Nausea—Lovastatin—atherosclerosis	0.000193	0.00175	CcSEcCtD
Amitriptyline—Rash—Simvastatin—atherosclerosis	0.000192	0.00174	CcSEcCtD
Amitriptyline—Dermatitis—Simvastatin—atherosclerosis	0.000191	0.00174	CcSEcCtD
Amitriptyline—Diarrhoea—Niacin—atherosclerosis	0.000191	0.00173	CcSEcCtD
Amitriptyline—Cyproheptadine—HRH1—atherosclerosis	0.000191	0.0348	CrCbGaD
Amitriptyline—Headache—Simvastatin—atherosclerosis	0.00019	0.00173	CcSEcCtD
Amitriptyline—Nausea—Ezetimibe—atherosclerosis	0.000189	0.00172	CcSEcCtD
Amitriptyline—Diarrhoea—Pravastatin—atherosclerosis	0.000188	0.0017	CcSEcCtD
Amitriptyline—Dizziness—Niacin—atherosclerosis	0.000185	0.00167	CcSEcCtD
Amitriptyline—CYP3A5—adipose tissue—atherosclerosis	0.000184	0.00606	CbGeAlD
Amitriptyline—Dizziness—Pravastatin—atherosclerosis	0.000182	0.00165	CcSEcCtD
Amitriptyline—Nausea—Simvastatin—atherosclerosis	0.000181	0.00164	CcSEcCtD
Amitriptyline—HRH1—adipose tissue—atherosclerosis	0.000179	0.00588	CbGeAlD
Amitriptyline—Vomiting—Niacin—atherosclerosis	0.000177	0.00161	CcSEcCtD
Amitriptyline—Rash—Niacin—atherosclerosis	0.000176	0.00159	CcSEcCtD
Amitriptyline—Dermatitis—Niacin—atherosclerosis	0.000176	0.00159	CcSEcCtD
Amitriptyline—ADRA2A—adipose tissue—atherosclerosis	0.000176	0.00578	CbGeAlD
Amitriptyline—Headache—Niacin—atherosclerosis	0.000175	0.00158	CcSEcCtD
Amitriptyline—Vomiting—Pravastatin—atherosclerosis	0.000175	0.00158	CcSEcCtD
Amitriptyline—Rash—Pravastatin—atherosclerosis	0.000173	0.00157	CcSEcCtD
Amitriptyline—Dermatitis—Pravastatin—atherosclerosis	0.000173	0.00157	CcSEcCtD
Amitriptyline—Headache—Pravastatin—atherosclerosis	0.000172	0.00156	CcSEcCtD
Amitriptyline—HTR2A—cardiovascular system—atherosclerosis	0.000169	0.00557	CbGeAlD
Amitriptyline—HTR7—liver—atherosclerosis	0.000168	0.00553	CbGeAlD
Amitriptyline—Thiothixene—HRH1—atherosclerosis	0.000167	0.0305	CrCbGaD
Amitriptyline—Nausea—Niacin—atherosclerosis	0.000166	0.0015	CcSEcCtD
Amitriptyline—CYP2C19—liver—atherosclerosis	0.000164	0.0054	CbGeAlD
Amitriptyline—Nausea—Pravastatin—atherosclerosis	0.000163	0.00148	CcSEcCtD
Amitriptyline—ADRA1A—liver—atherosclerosis	0.000162	0.00533	CbGeAlD
Amitriptyline—Mianserin—HRH1—atherosclerosis	0.000145	0.0263	CrCbGaD
Amitriptyline—CYP2C8—liver—atherosclerosis	0.000143	0.00471	CbGeAlD
Amitriptyline—CYP1A2—liver—atherosclerosis	0.000134	0.00441	CbGeAlD
Amitriptyline—Chlorprothixene—HRH1—atherosclerosis	0.000132	0.024	CrCbGaD
Amitriptyline—CYP3A5—liver—atherosclerosis	0.000129	0.00425	CbGeAlD
Amitriptyline—Nortriptyline—HRH1—atherosclerosis	0.000129	0.0235	CrCbGaD
Amitriptyline—CYP2B6—liver—atherosclerosis	0.000128	0.00422	CbGeAlD
Amitriptyline—CYP2C9—liver—atherosclerosis	0.000127	0.00418	CbGeAlD
Amitriptyline—Trimipramine—HRH1—atherosclerosis	0.000122	0.0222	CrCbGaD
Amitriptyline—CYP2E1—liver—atherosclerosis	0.000121	0.00396	CbGeAlD
Amitriptyline—Diphenhydramine—HRH1—atherosclerosis	0.000119	0.0218	CrCbGaD
Amitriptyline—Promethazine—HRH1—atherosclerosis	0.000117	0.0213	CrCbGaD
Amitriptyline—Doxepin—HRH1—atherosclerosis	0.000116	0.0211	CrCbGaD
Amitriptyline—Orphenadrine—HRH1—atherosclerosis	0.000113	0.0206	CrCbGaD
Amitriptyline—ABCB1—cardiovascular system—atherosclerosis	0.000111	0.00365	CbGeAlD
Amitriptyline—Desipramine—HRH1—atherosclerosis	0.000106	0.0194	CrCbGaD
Amitriptyline—HTR2A—liver—atherosclerosis	0.000105	0.00345	CbGeAlD
Amitriptyline—Promazine—HRH1—atherosclerosis	0.000103	0.0188	CrCbGaD
Amitriptyline—ABCB1—adipose tissue—atherosclerosis	9.79e-05	0.00322	CbGeAlD
Amitriptyline—CYP3A4—liver—atherosclerosis	9.7e-05	0.00319	CbGeAlD
Amitriptyline—CYP2D6—liver—atherosclerosis	9.54e-05	0.00314	CbGeAlD
Amitriptyline—Imipramine—HRH1—atherosclerosis	9.02e-05	0.0164	CrCbGaD
Amitriptyline—ABCB1—liver—atherosclerosis	6.86e-05	0.00226	CbGeAlD
Amitriptyline—Oxcarbazepine—ALB—atherosclerosis	5.32e-05	0.00968	CrCbGaD
Amitriptyline—Thiothixene—ALB—atherosclerosis	3.86e-05	0.00704	CrCbGaD
Amitriptyline—Clomipramine—ALB—atherosclerosis	3.05e-05	0.00556	CrCbGaD
Amitriptyline—Nortriptyline—ALB—atherosclerosis	2.98e-05	0.00544	CrCbGaD
Amitriptyline—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	1.67e-06	1.39e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.66e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—APOE—atherosclerosis	1.66e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CAV1—atherosclerosis	1.66e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—AKT1—atherosclerosis	1.66e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—APOA1—atherosclerosis	1.65e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	1.65e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GPX1—atherosclerosis	1.65e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—atherosclerosis	1.65e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	1.64e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CAV1—atherosclerosis	1.64e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MMP9—atherosclerosis	1.64e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.64e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—APOA1—atherosclerosis	1.64e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MMP9—atherosclerosis	1.63e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	1.63e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	1.62e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	1.62e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—atherosclerosis	1.62e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—atherosclerosis	1.61e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	1.61e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CD36—atherosclerosis	1.61e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.6e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	1.6e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MAPK3—atherosclerosis	1.6e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	1.6e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—ALB—atherosclerosis	1.6e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IL6—atherosclerosis	1.59e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CXCL8—atherosclerosis	1.59e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	1.59e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	1.59e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PPARG—atherosclerosis	1.59e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	1.58e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	1.57e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	1.57e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CXCL8—atherosclerosis	1.57e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	1.56e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	1.56e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	1.56e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—INS—atherosclerosis	1.55e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	1.55e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TGFB1—atherosclerosis	1.55e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	1.55e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PPARG—atherosclerosis	1.55e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	1.54e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	1.54e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	1.54e-06	1.28e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—NOS3—atherosclerosis	1.53e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.52e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	1.52e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—NOS3—atherosclerosis	1.52e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—INS—atherosclerosis	1.52e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	1.52e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—IL6—atherosclerosis	1.52e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	1.52e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	1.51e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.51e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.51e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	1.5e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.5e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARA—atherosclerosis	1.49e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—IL6—atherosclerosis	1.49e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—IL6—atherosclerosis	1.49e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	1.49e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.48e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—IL6—atherosclerosis	1.48e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—IL6—atherosclerosis	1.48e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	1.47e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—AKT1—atherosclerosis	1.47e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	1.47e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—IL6—atherosclerosis	1.46e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.46e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—STAT3—atherosclerosis	1.46e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PPARG—atherosclerosis	1.46e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—STAT3—atherosclerosis	1.45e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AGT—atherosclerosis	1.45e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PPARG—atherosclerosis	1.45e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MMP9—atherosclerosis	1.44e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—INS—atherosclerosis	1.43e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.43e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	1.43e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NFKB1—atherosclerosis	1.43e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ALB—atherosclerosis	1.43e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MMP9—atherosclerosis	1.42e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—APOE—atherosclerosis	1.42e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—INS—atherosclerosis	1.42e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MMP9—atherosclerosis	1.42e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MMP9—atherosclerosis	1.41e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MMP9—atherosclerosis	1.41e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CAV1—atherosclerosis	1.4e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	1.4e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	1.4e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK8—atherosclerosis	1.4e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—APOA1—atherosclerosis	1.4e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NFKB1—atherosclerosis	1.4e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—AKT1—atherosclerosis	1.4e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IL6—atherosclerosis	1.4e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.4e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	1.4e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	1.4e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MMP9—atherosclerosis	1.39e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	1.39e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—ALB—atherosclerosis	1.39e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	1.39e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.39e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—atherosclerosis	1.39e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	1.39e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	1.38e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	1.38e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	1.38e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—atherosclerosis	1.38e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK8—atherosclerosis	1.38e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—atherosclerosis	1.38e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	1.38e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.37e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—atherosclerosis	1.37e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	1.37e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	1.37e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	1.37e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—atherosclerosis	1.37e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—APOB—atherosclerosis	1.37e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	1.36e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—NOS3—atherosclerosis	1.36e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	1.36e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	1.35e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	1.35e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	1.35e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.35e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.35e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	1.35e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—atherosclerosis	1.34e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—NOS3—atherosclerosis	1.33e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.33e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	1.33e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ALB—atherosclerosis	1.31e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—LPL—atherosclerosis	1.31e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—atherosclerosis	1.3e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ALB—atherosclerosis	1.3e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—atherosclerosis	1.29e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	1.29e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—atherosclerosis	1.29e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.29e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STAT3—atherosclerosis	1.28e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.28e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	1.28e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	1.27e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GPX1—atherosclerosis	1.27e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—atherosclerosis	1.27e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—atherosclerosis	1.27e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—atherosclerosis	1.27e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	1.27e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	1.26e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—atherosclerosis	1.26e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STAT3—atherosclerosis	1.26e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STAT3—atherosclerosis	1.26e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	1.26e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STAT3—atherosclerosis	1.25e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—NOS3—atherosclerosis	1.25e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	1.25e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	1.25e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STAT3—atherosclerosis	1.25e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.25e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.25e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—atherosclerosis	1.24e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—NOS3—atherosclerosis	1.24e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CD36—atherosclerosis	1.24e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STAT3—atherosclerosis	1.24e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—atherosclerosis	1.24e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.24e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARG—atherosclerosis	1.24e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK3—atherosclerosis	1.22e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—atherosclerosis	1.22e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—INS—atherosclerosis	1.21e-06	1.01e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	1.21e-06	1e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK3—atherosclerosis	1.2e-06	9.99e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—atherosclerosis	1.2e-06	9.96e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.2e-06	9.96e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.2e-06	9.93e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TGFB1—atherosclerosis	1.19e-06	9.88e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.18e-06	9.83e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—atherosclerosis	1.18e-06	9.82e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.18e-06	9.81e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.18e-06	9.77e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—atherosclerosis	1.17e-06	9.73e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—atherosclerosis	1.17e-06	9.73e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	1.17e-06	9.72e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TGFB1—atherosclerosis	1.17e-06	9.7e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.16e-06	9.66e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.16e-06	9.63e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.16e-06	9.63e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARA—atherosclerosis	1.15e-06	9.58e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—atherosclerosis	1.15e-06	9.54e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.15e-06	9.54e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.15e-06	9.54e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.15e-06	9.53e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.15e-06	9.51e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.14e-06	9.45e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AGT—atherosclerosis	1.12e-06	9.28e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ALB—atherosclerosis	1.11e-06	9.23e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.1e-06	9.11e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—APOE—atherosclerosis	1.09e-06	9.09e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—atherosclerosis	1.09e-06	9.06e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CAV1—atherosclerosis	1.08e-06	9.01e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—APOA1—atherosclerosis	1.08e-06	8.99e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—atherosclerosis	1.08e-06	8.97e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	1.08e-06	8.97e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.06e-06	8.84e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—NOS3—atherosclerosis	1.06e-06	8.83e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.02e-06	8.48e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—atherosclerosis	1.01e-06	8.43e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CG—atherosclerosis	9.88e-07	8.21e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—atherosclerosis	9.72e-07	8.07e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—atherosclerosis	9.71e-07	8.07e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—atherosclerosis	9.64e-07	8.01e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARG—atherosclerosis	9.53e-07	7.92e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—atherosclerosis	9.41e-07	7.82e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—atherosclerosis	9.36e-07	7.78e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—INS—atherosclerosis	9.35e-07	7.77e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	8.96e-07	7.45e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—atherosclerosis	8.96e-07	7.44e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—atherosclerosis	8.85e-07	7.35e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—atherosclerosis	8.81e-07	7.32e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—atherosclerosis	8.79e-07	7.31e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—atherosclerosis	8.77e-07	7.28e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—atherosclerosis	8.74e-07	7.26e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—atherosclerosis	8.65e-07	7.19e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—atherosclerosis	8.63e-07	7.17e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ALB—atherosclerosis	8.57e-07	7.12e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—atherosclerosis	8.29e-07	6.89e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—atherosclerosis	8.26e-07	6.87e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NOS3—atherosclerosis	8.2e-07	6.81e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—atherosclerosis	8.13e-07	6.75e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—atherosclerosis	8.12e-07	6.75e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—atherosclerosis	8.11e-07	6.74e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—atherosclerosis	8.11e-07	6.74e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—atherosclerosis	8.09e-07	6.72e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—atherosclerosis	8.06e-07	6.7e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—atherosclerosis	8.02e-07	6.66e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—atherosclerosis	7.98e-07	6.63e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	7.96e-07	6.61e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—atherosclerosis	7.5e-07	6.23e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	7.4e-07	6.15e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—atherosclerosis	7.02e-07	5.83e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—atherosclerosis	6.98e-07	5.8e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—atherosclerosis	6.27e-07	5.21e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—atherosclerosis	6.12e-07	5.08e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—atherosclerosis	5.76e-07	4.79e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—atherosclerosis	5.71e-07	4.75e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—atherosclerosis	4.88e-07	4.06e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—atherosclerosis	3.77e-07	3.13e-06	CbGpPWpGaD
